Shear-thinning biomaterial-based minimally invasive strategy for delivery of targeted immunotherapy By admin | August 2, 2022 0 Comment Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed and optimized a minimally invasive method for more targeted, efficient, and sustained delivery of immunotherapeutic treatments for cancer.